Ryde Group Ltd partners with Mobile-health Network Solutions

SINGAPORE–(BUSINESS WIRE)–Ryde Group Ltd (NYSE American: RYDE) (“Ryde” or “the Company”), a leading technology platform for mobility and quick commerce, today announced a partnership with Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr”), the first US listed telehealth provider in Asia Pacific. Ryde and MaNaDr signed a definitive partnership agreement to further collaboration in the telehealth and quick commerce space.




This collaboration aims to enhance the well-being of Ryde’s driver-partners and their families by providing them with greater access to affordable healthcare services. It underscores our commitment for the driver-partners and their families to benefit from convenient telemedicine consultations, making healthcare readily available even while on the road. By allowing quick consultations for common illnesses or injuries, it minimizes downtime and maximizes earning potential, addressing a major concern for driver-partners.

Key Partnership Benefits:

Members’ rate Telemedicine Consultations: All Ryde driver-partners and their families can access MaNaDr’s 24/7 telemedicine platform at members’ rates, enabling convenient and cost-effective medical consultations.

Increased Brand Awareness: Both companies will engage in a joint marketing campaign to promote each other’s services to their respective user bases.

Potential for Future Growth: Both companies will look to explore more opportunities in the future.

Terence Zou, CEO and Founder of Ryde Group expressed, “We are committed to the well-being of our driver-partners. This business partnership gives them and their families convenient access to healthcare solutions, fostering a strong and loyal driver community for Ryde. We also believe this marketing collaboration strengthens Ryde’s position as a super mobility app by tapping into MaNaDr’s sizable user base.”

Dr. Siaw Tung Yeng, PBM, Senior Consultant Family Physician and MaNaDr co-CEO shared, “Ride-hailing drivers are recognized in Singapore as savvy consumers. Ryde’s extensive network of driver-partners presents a valuable opportunity to raise awareness of the benefits of telehealth services across Singapore. We believe this would likely result in Mobile-health Network Solutions receiving a significant influx of new patients and contribute to the growth of the telehealth industry in Singapore.”

About Ryde Group Ltd

Ryde is a super mobility app founded in Singapore and also the world’s FIRST on-demand carpooling app since 2014. As a publicly listed company on the NYSE American, FSE and XSTU stock exchange, we are reimagining the way people and goods move around. We offer a full suite of services, including carpooling, private hire, taxi, and delivery, but what truly sets us apart is our commitment to empower our private-hire and taxi partners. We take 0% commission, ensuring that more of every hard-earned dollar goes to drivers on our platform. For more information, please visit https://rydesharing.com/ to learn more.

About Mobile-health Network Solutions

Ranked #41 in Financial Times 2024 listing of 500 High-growth Asia-Pacific Companies, MNDR is the first telehealth provider from the Asia-Pacific region to be listed in the US. Through its MaNaDr platform, the Company offers personalized and reliable medical attention to users worldwide. This platform allows its community of healthcare providers to have a broader reach to users through virtual clinics without any start-up costs and the ability to connect to a global network of peer-to-peer support groups and partners. The Company’s range of seamless and hassle-free telehealth solutions includes teleconsultation services, prescription fulfillment and other personalized services such as weight management programs and gender-specific care. For more information, please visit https://investors.manadr.com/.

FORWARD-LOOKING STATEMENTS

Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and the completion of the public offering on the anticipated terms or at all, and other factors discussed in the “Risk Factors” section of the preliminary prospectus filed with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof, and Ryde Group Ltd specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

Contacts

For Media Relations:

Media Team

Ryde Group Ltd

Email: [email protected]

For Investor Relations:

Investor Relations Team

Ryde Group Ltd

Email: [email protected]

Skyline Corporate Communications Group, LLC

Email: [email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.